Boehringer Ingelheim Registers Phase III COPD Trial for Verducatib
Boehringer Ingelheim registered the AIRWARD Phase III trial investigating verducatib in COPD on ClinicalTrials.gov (NCT07907991).
Boehringer Ingelheim registered the AIRWARD Phase III trial investigating verducatib in COPD on ClinicalTrials.gov (NCT07907991).